These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
25. Blood dyscrasias with carbamazepine and valproate: a pharmacoepidemiological study of 2,228 patients at risk. Tohen M; Castillo J; Baldessarini RJ; Zarate C; Kando JC Am J Psychiatry; 1995 Mar; 152(3):413-8. PubMed ID: 7864268 [TBL] [Abstract][Full Text] [Related]
26. [Blood damage from alcohol]. Bottiger LE Lakartidningen; 1976 Nov; 73(47):4099-101. PubMed ID: 994602 [No Abstract] [Full Text] [Related]
28. Drug-associated disease: hematologic dysfunction. Vandendries ER; Drews RE Crit Care Clin; 2006 Apr; 22(2):347-55, viii. PubMed ID: 16678004 [TBL] [Abstract][Full Text] [Related]
29. Detection of drug-induced blood dyscrasias. Swanson M; Cook R Am J Hosp Pharm; 1973 Jun; 30(6):534-7. PubMed ID: 4709935 [No Abstract] [Full Text] [Related]
30. Hematologic toxicity of immunosuppressive treatment. Danesi R; Del Tacca M Transplant Proc; 2004 Apr; 36(3):703-4. PubMed ID: 15110637 [TBL] [Abstract][Full Text] [Related]
31. [Hemolytic anemia and thrombocytopenia induced by cimetidine: recurrence with ranitidine administration]. Takimoto R; Mogi Y; Kura T; Niitsu Y Rinsho Ketsueki; 1997 Feb; 38(2):124-8. PubMed ID: 9059066 [TBL] [Abstract][Full Text] [Related]
32. [Evaluation of the bone marrow in patients with brucellosis. Clinico-pathological correlation]. García P; Yrivarren JL; Argumans C; Crosby E; Carrillo C; Gotuzzo E Enferm Infecc Microbiol Clin; 1990 Jan; 8(1):19-24. PubMed ID: 2095900 [TBL] [Abstract][Full Text] [Related]
33. Trimethoprim-sulphamethoxazole-associated blood dyscrasias. Ten years' experience of the Swedish spontaneous reporting system. Keisu M; Wiholm BE; Palmblad J J Intern Med; 1990 Oct; 228(4):353-60. PubMed ID: 2266345 [TBL] [Abstract][Full Text] [Related]
34. Adverse effects of drugs on the blood. Meulenhoff JS Pharm Weekbl Sci; 1984 Feb; 6(1):39-47. PubMed ID: 6709484 [TBL] [Abstract][Full Text] [Related]
35. Dose intensity and hematologic toxicity in older breast cancer patients receiving systemic chemotherapy. Shayne M; Culakova E; Wolff D; Poniewierski MS; Dale DC; Crawford J; Lyman GH Cancer; 2009 Nov; 115(22):5319-28. PubMed ID: 19672945 [TBL] [Abstract][Full Text] [Related]
36. Drug-induced blood dyscrasias. Casey TP N Z Med J; 1968 Jun; 67(433):599-606. PubMed ID: 4877026 [No Abstract] [Full Text] [Related]
37. Ceftriaxone causes drug-induced immune thrombocytopenia and hemolytic anemia: characterization of targets on platelets and red blood cells. Grossjohann B; Eichler P; Greinacher A; Santoso S; Kroll H Transfusion; 2004 Jul; 44(7):1033-40. PubMed ID: 15225244 [TBL] [Abstract][Full Text] [Related]
38. Risk of clinical blood dyscrasia in a cohort of antibiotic users. Huerta C; García Rodríguez LA Pharmacotherapy; 2002 May; 22(5):630-6. PubMed ID: 12013362 [TBL] [Abstract][Full Text] [Related]